Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)

T. J. Stankowski-Drengler, J. R. Schumacher, B. Hanlon, D. Livingston-Rosanoff, K. Van de Walle, C. C. Greenberg, L. G. Wilke, H. B. Neuman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)'. Together they form a unique fingerprint.

Medicine & Life Sciences